Prestige Consumer Healthcare (PBH) Invested Capital (2010 - 2025)

Prestige Consumer Healthcare's Invested Capital history runs 16 years deep, the most recent figure standing at $2.9 billion for Q4 2025.

• In Q4 2025, Invested Capital rose 59.64% year-over-year to $2.9 billion; the TTM figure through Dec 2025 stood at $2.9 billion (up 59.64% YoY), while the FY2025 annual figure was $2.8 billion, up 1.67% from the prior year.
• Invested Capital was $2.9 billion for Q4 2025 at Prestige Consumer Healthcare, up from $1.8 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $3.1 billion in Q3 2022 to a low of $1.4 billion in Q2 2021.
• Historically, Invested Capital has averaged $2.3 billion across 5 years, with a median of $2.8 billion in 2024.
• The sharpest annual moves came in 2021 and 2023: Invested Capital surged 136.92% in 2021, then sank 51.46% in 2023.
• A 5-year view of Invested Capital shows it stood at $1.5 billion in 2021, then climbed by 10.9% to $1.7 billion in 2022, then slipped by 5.27% to $1.6 billion in 2023, then gained by 11.88% to $1.8 billion in 2024, then jumped by 59.64% to $2.9 billion in 2025.
• The last three Invested Capital figures came in at $2.9 billion (Q4 2025), $1.8 billion (Q3 2025), and $1.9 billion (Q2 2025), per Business Quant data.